Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
23 studies found for:    uPAR
Show Display Options
Rank Status Study
1 Not yet recruiting uPAR PET/CT in Radium-223-dichloride Treatment of Patients With Metastatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer Metastatic;   Bone Metastases
Interventions: Drug: Injection of PET tracer 68Ga-NOTA-AE105;   Device: PET/CT
2 Recruiting uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
Conditions: Oral Cancer;   Oropharyngeal Cancer;   Neoplasms;   Head and Neck Neoplasms;   Cancer of Mouth;   Neoplasms by Site
Intervention: Other: 68Ga-NOTA-AE105 PET/CT
3 Not yet recruiting uPAR-PET/MRI in Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: One injection of 68Ga-NOTA-AE105;   Device: PET/MRI
4 Recruiting uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Drug: Injection of 18F-FDG;   Device: Positron Emission Tomography and CT;   Device: Positron Emission Tomography and MRI
5 Recruiting uPAR PET/CT for Preoperative Staging of Breast Cancer Patients
Condition: Breast Cancer
Interventions: Other: 68Ga-NOTA-AE105;   Device: Positron Emission Tomography PET/CT
6 Recruiting Phase II Trial: uPAR-PET/CT for Prognostication in Head- and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Drug: 68Ga-NOTA-AE105
7 Terminated Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Abiraterone;   Drug: Prednisolone
8 Completed Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Interventions: Drug: Injection of 68Ga-NOTA-AE105;   Device: Positron Emission Tomography scans
9 Recruiting uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
Conditions: Non-small Cell Lung Cancer;   Malignant Pleural Mesothelioma;   Large Cell Neuroendocrine Carcinoma of the Lung
Intervention: Other: 68Ga-NOTA-AE105 PET/CT
10 Completed Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Intervention: Other: Injection of 64Cu-DOTA-AE105
11 Completed Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia
Condition: BPH
Intervention: Procedure: transurethral resection of the prostate
12 Unknown  Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Late-onset Neonatal Sepsis
Condition: Neonatal Sepsis
Intervention:
13 Unknown  GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy
Condition: Prostate Cancer
Interventions: Other: Low Dose GTN 0.0285 mg/hr;   Other: High Dose GTN 0.057 mg/hr;   Other: Placebo
14 Completed Dietary Seaweed and Early Breast Cancer: A Randomized Trial
Condition: Seaweed Associated Changes in Healthy Subjects
Interventions: Other: Seaweed;   Other: Placebo;   Other: Placebo2
15 Recruiting suPAR in the Early Diagnosis of Acute Kidney Injury(AKI) After On-Pump Cardiac Surgery
Condition: Acute Kidney Injury
Intervention:
16 Recruiting A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients
Condition: FSGS
Intervention:
17 Unknown  Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
Conditions: Breast Neoplasms;   Mastectomy
Intervention: Drug: Solu-medrol 125 mg
18 Not yet recruiting Prostaglandin E2 Predicts the Outcome of Acute-on-chronic Liver Failure
Conditions: Acute-On-Chronic Liver Failure;   Cirrhosis and Chronic Liver Disease
Intervention:
19 Recruiting Role of SLURP-1 in Melanoma and Melanoma Stem Cells
Condition: Melanoma;
Intervention:
20 Recruiting Clinical Evaluation of Novel Biomarkers in Patients With Septicemia
Conditions: Sepsis;   Bacteremia;   Fungemia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.